Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Novel Biomarkers for Neoplastic Progression From Ulcerative Colitis to Colorectal Cancer: A Systems Biology Approach Publisher Pubmed



Shahnazari M2 ; Afshar S2 ; Emami MH3 ; Amini R2 ; Jalali A2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Hamadan University of Medical Sciences, Hamadan, Iran
  2. 2. Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
  3. 3. Poursina Hakim, Digestive Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Scientific Reports Published:2023


Abstract

In recent studies, the void of evaluation and in-depth understanding of unknown clinically relevant potential molecular biomarkers involved in colorectal cancer (CRC) from the inflammatory stage of ulcerative colitis (UC) to CRC metastasis, which can be suitable therapeutic targets, is deeply felt. The regulation and interaction among different cancer-promoting molecules, including messenger RNAs (mRNAs) and micro RNAs (miRNAs) in CRC and its progression, were the aim we pursued in this study. Using microarray data, we investigated the differential expression for five datasets, including mRNA and microRNA samples related to UC, tumor/normal. Then, using robust data analysis, separate lists of differentially expressed genes (DEGs) and differentially expressed miRNAs (DEmiRNAs) were identified, which were used for robust rank aggregation (RRA) and co-expression network analysis. Then, comprehensive computational systems biology analyses, including gene ontology and Kyoto encyclopedia of genes and genomic pathway enrichment analyses, mRNA-miRNA regulatory network, and survival analysis, were employed to achieve the aim of this study. Finally, we used clinical samples to validate this potential and new target. According to this systems biology approach, a total of 98 DEGs and 8 DEmiRNAs with common differential expression were identified. By combining the distinct results of RRA and network, several potential therapeutic targets, and predictive and prognostic biomarkers for UC and CRC were identified. These targets include six common hub genes, CXCL1, CXCL8, MMP7, SLCA16A9, PLAU, and TIMP1, which are upregulated. Among these, the important and new biomarker SLC16A9 is negatively regulated by hsa-mir-194-5p, and hsa-miR-378a-5p take. The findings of the present study provide new insight into the pathogenesis of CRC in UC. Our study suggests future evaluation of the functional role of SLC16A9 and hsa-mir-194-5p and hsa-miR-378a-5p in CRC development. © 2023, The Author(s).
Other Related Docs
26. Mir-370 Expression Analysis in Breast Cancer, Journal of Isfahan Medical School (2015)
34. Emerging Roles for Lncrna-Neat1 in Colorectal Cancer, Cancer Cell International (2022)
39. Microrna Profiles in Critically Ill Patients, Current Medicinal Chemistry (2024)
43. Long Non-Coding Rnas As Potential Biomarkers or Therapeutic Targets in Gastric Cancer, Gastroenterology and Hepatology from Bed to Bench (2023)
44. Early Detection of Colorectal Cancer: From Conventional Methods to Novel Biomarkers, Journal of Cancer Research and Clinical Oncology (2016)
48. Network Analysis of Common Genes Related to Esophageal, Gastric, and Colon Cancers, Gastroenterology and Hepatology from Bed to Bench (2017)